- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06800040
Testing a Group Memory Training Program for People With Brain Injuries
Evaluating the Feasibility and Effectiveness of a Group-Based Memory Rehabilitation Program for Acquired Brain Injury (ABI) Patients
The purpose of this study is to assess the feasibility, acceptability, and effectiveness of a 6-week group-based memory training program for individuals experiencing memory problems after acquired brain injury (ABI).
Memory impairment is a prevalent consequence of neurological disorders like stroke, traumatic brain injury (TBI), anoxia, brain tumours, or brain infections, collectively termed acquired brain injury (ABI). While memory rehabilitation has shown promise in improving cognitive function in ABI patients, individualised treatments can be resource-intensive and not readily accessible to all in need.
The program "Group-Based Memory Rehabilitation to Improve Memory for Everyday Tasks" offers an evidence-based, group-based intervention. Previous studies have demonstrated its efficacy in enhancing everyday memory function, including increased use of memory strategies, achievement of memory-related goals, and improvements in learning ability, both in the subacute and chronic phase post-injury. Furthermore, recent investigations have shown comparable efficacy when delivering the program through telehealth platforms (video conferencing).
The investigators have meticulously translated and adapted the memory program to suit Norwegian conditions. As far as the investigators are aware, this is the first time the program has undergone translation and adaptation for Norwegian speakers.
This study aims to evaluate the memory program's feasibility, acceptability, and effectiveness in a Norwegian context, aiming to support its implementation in local health services. Both physical face-to-face groups as well as telehealth delivery through videoconferencing will be evaluated. Telehealth delivery will be utilised to overcome geographical barriers and enhance accessibility for patients residing in rural or remote areas in Northern Norway, where rehabilitation services are recognized as an unmet need. A total of five groups will be run during 2025 and 2026. Three of the three groups will be digital via videoconferencing.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This manualized, group-based memory intervention involves six weekly, two-hour sessions (including a break). Group sizes should be from 3 to 10 participants, as recommended by the developers, with two group leaders (psychologists/neuropsychologists). Each session encompasses education about memory and factors influencing optimal memory function, and training in the use of compensatory memory strategies (both internal strategies and external memory aids). Group exercises and discussions, as well as homework tasks between sessions, are used to facilitate learning and generalisation of memory skills. The two-hour sessions are divided into approximately 15 minutes for reviewing homework and repetition from previous sessions; 20-30 minutes for the educational component; 60-80 minutes for practising strategies and discussing their application; 10 minutes for a break. Full details of the memory intervention, including instructional guidelines, description of exercises, handouts and supporting materials, can be found in the published manual.
The memory training program will constitute a new treatment intervention in the health region of Northern Norway, and the need to carry out feasibility studies as part of the development of complex interventions has been pointed out. Hence, the objective of this study is to identify and evaluate obstacles to delivery and implementation of the program through a feasibility and acceptability study. Effectiveness of the intervention will depend on sufficient feasibility, and will also be evaluated.
The study has two aims. First, the investigators aim to explore the feasibility of delivering the intervention, and the patients acceptability of the intervention, in order to achieve optimal efficacy.
Second, the investigators will explore the effectiveness of the memory training program on participants' memory functioning.
Research question 1 What is the feasibility of the intervention, considering a) the demand for the treatment as assessed through a) Recruitment, b) Adherence, c) Acceptability by participants, and d) Format of delivery.
Research question 2 Does a group-based 6 week memory training program improve objective and subjective memory functioning in individuals with memory complaints after ABI? The aim of the program is to enhance memory functioning on one or more measures of subjective and objective memory, number of memory strategies used in daily life, and/or personal goal attainment.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Tromsø, Norway
- University Hospital of North Norway
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- history of ABI (stroke/cerebrovascular incidents, traumatic brain injury, anoxia, non-progressive brain tumour, brain infection, or other non-progressive ABI) at least 6 months prior to inclusion.
- memory problems.
- sufficient Norwegian language skills to participate in assessments and group treatment.
- age between 18 and 75 years.
Exclusion Criteria:
- diagnosis of comorbid progressive neurodegenerative disorder, or serious major somatic or psychiatric conditions (e.g bipolar disorder, psychosis, severe depression)
- major cognitive impairment preventing assessment and group participation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Memory training
|
Memory training
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility of memory training intervention: Demand for the treatment
Time Frame: From enrollment to the end of follow up 3 months after the intervention
|
The demand for the treatment will be assessed by number of participants enrolled.
|
From enrollment to the end of follow up 3 months after the intervention
|
|
Feasibility of memory training intervention: Adherence
Time Frame: From enrollment to the end of follow up 3 months after the intervention
|
Adherence to treatment will be measured by dropout rate.
|
From enrollment to the end of follow up 3 months after the intervention
|
|
Feasibility of memory training intervention: Acceptability by participants
Time Frame: From enrollment to the end of follow up 3 months after the intervention
|
Acceptability by participants will be assessed through perceptions of usefulness, measured by responses to evaluation forms.
|
From enrollment to the end of follow up 3 months after the intervention
|
|
Feasibility of memory training intervention: Format of delivery
Time Frame: From enrollment to the end of follow up 3 months after the intervention
|
Acceptability of format of delivery (face-to-face and/or telehealth attendance) will be assessed through responses to evaluation forms.
|
From enrollment to the end of follow up 3 months after the intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Strategy use
Time Frame: From enrollment to the end of follow up 3 months after the intervention
|
Description of type and number of internal and external memory strategies participants employ in their everyday life before and after the intervention, will be registered with pre- and post-evaluation forms from the published manual.
|
From enrollment to the end of follow up 3 months after the intervention
|
|
Objective verbal memory functioning
Time Frame: From enrollment to the end of follow up 3 months after the intervention
|
Memory impairment/objective memory functioning will be assessed with standardised a neuropsychological test of verbal memory (Rey Auditory Verbal Learning Test - RAVLT).
|
From enrollment to the end of follow up 3 months after the intervention
|
|
Objective visual memory functioning
Time Frame: From enrollment to the end of follow up 3 months after the intervention
|
Memory impairment/objective memory functioning will be assessed with a standardised neuropsychological tests of visual memory (Brief Visuospatial Memory Test-Revised - BVMT-R).
|
From enrollment to the end of follow up 3 months after the intervention
|
|
Memory training effectiveness
Time Frame: From enrollment to the end of follow up 3 months after the intervention
|
Subjective memory problems in everyday life will be measured by responses to The Everyday Memory Questionnaire - revised (EMQ-R).
The EMQ-R is a 13-item scale developed as a measure of self-reported memory failures of everyday life.
It is evaluated with a five-point Likert scale whereby higher scores indicate greater frequency of memory lapses.
|
From enrollment to the end of follow up 3 months after the intervention
|
|
Memory training effectiveness
Time Frame: From enrollment to the end of follow up 3 months after the intervention
|
Subjective memory problems in everyday life will be measured by responses to the Prospective and Retrospective Memory Questionnaire (PRMQ).
The Prospective and Retrospective Memory Questionnaire (PRMQ) is a self-report measure of prospective and retrospective memory slips in everyday life, which allows participants to rate the frequency of the two forms of memory failures on a five-point Likert-scale, ranging from "very often" (5) to "never" (1).
It is a 16-item scale, 8 items asking about prospective memory failures, and 8 concerning retrospective memory failures.
|
From enrollment to the end of follow up 3 months after the intervention
|
|
Personal memory goal
Time Frame: From enrollment to the end of follow up 3 months after the intervention
|
Two personal memory goals will be set at baseline and self-reported attainment assessed before and after treatment using Goal Attainment Scaling (GAS).
Goal attainment is rated on a 5-point scale from -2 (current level) to +2 (much more than expected).
The expected level of goal attainment is scored as 0 by the participant.
|
From enrollment to the end of follow up 3 months after the intervention
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Objective attention functioning
Time Frame: From enrollment to the end of follow up 3 months after the intervention
|
Objective attention functioning will be assessed with the Trail Making Test (TMT) A & B.
|
From enrollment to the end of follow up 3 months after the intervention
|
|
Emotional symptoms/distress
Time Frame: From enrollment to the end of follow up 3 months after the intervention
|
Emotional distress will be measured with the Hopkins Symptoms Checklist-10 (SCL-10).
The SCL-10 questionnaire employs a four-point Likert scale for each of 10 items, ranging from 1 ("not at all") to 4 ("extremely").
The scoring system is designed so that higher scores indicate increased mental health distress symptoms.
|
From enrollment to the end of follow up 3 months after the intervention
|
|
Emotional Well-being
Time Frame: From enrollment to the end of follow up 3 months after the intervention
|
The World Health Organisation Five Well-Being Index (WHO-5) will be used to measure general well-being.
The WHO-5 asks respondents to rate their interest, engagement, and mood on five questions, and the final score ranges from 0 (very poor well-being) to 100 (excellent well-being).
|
From enrollment to the end of follow up 3 months after the intervention
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- REC North ID nr. 793668
- 38355/HNI0056-24 (Other Identifier: Innovation Centre, Northern Norway Regional Health Authority)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acquired Brain Injury (Including Stroke)
-
Danderyd HospitalStiftelsen PromobilaNot yet recruitingAcquired Brain Injury (Including Stroke)Sweden
-
Klimmendaal RevalidatiespecialistenDonders Centre for Cognitive NeuroimagingRecruitingAcquired Brain Injury (Including Stroke)Netherlands
-
Duquesne UniversityEnrolling by invitationCaregivers | Acquired Brain Injury (Including Stroke)United States
-
University at BuffaloWake Forest University Health Sciences; U.S. Department of Education; Massey... and other collaboratorsCompletedAcquired Brain Injury (Including Stroke)United States, New Zealand, Canada
-
King's College LondonNot yet recruitingAcquired Brain Injury Including Stroke
-
ABLE Human Motion S.L.Centro Europeo de Neurociencias (CEN); Cefine Neurología (CEFINE); Fundación...CompletedAcquired Brain Injury (Including Stroke)Spain
-
University of GuelphHamilton Health Sciences Corporation; Natural Sciences and Engineering Research...UnknownAcquired Brain Injury Including Stroke
-
Norfolk and Norwich University Hospitals NHS Foundation...University of East Anglia; 3 Million Steps charityCompletedAcquired Brain Injury (Including Stroke)United Kingdom
-
Fondazione Don Carlo Gnocchi OnlusUniversity of FlorenceRecruitingIntensive Care Unit (ICU) Acquired Weakness (ICU - AW) | Acquired Brain Injury (Including Stroke)Italy
-
University of OxfordNot yet recruitingAcquired Brain Injury (Including Stroke)United Kingdom
Clinical Trials on Memory training
-
Johns Hopkins UniversityTerminatedSubstance-Related DisordersUnited States
-
Jeffrey MotterAlzheimer's AssociationRecruiting
-
Icahn School of Medicine at Mount SinaiCompletedDepression | Generalized Anxiety Disorder | Bipolar Disorder | Major Depressive Disorder | Social Phobia | Post-traumatic Stress DisorderUnited States
-
Wayne State UniversityRecruitingBehavior, HealthUnited States
-
University of GeorgiaRecruitingSchizophrenia | Schizo Affective DisorderUnited States
-
Milwaukee VA Medical CenterCompletedPosttraumatic Stress DisorderUnited States
-
VA Office of Research and DevelopmentUniversity of MarylandCompleted
-
University of CalgaryBrain & Behavior Research FoundationTerminatedPsychotic Disorders
-
Radboud University Medical CenterNetherlands Organisation for Scientific ResearchCompletedAttention Deficit Disorder With HyperactivityNetherlands
-
Kessler FoundationNot yet recruiting